LBL meaning in pharma
Leave-Behind Literature is designed to remain with the doctor or healthcare professional after the representative leaves. Its purpose is generally different from the main detailing visual aid: instead of guiding the live conversation page by page, it provides a compact reference that can support recall of the approved product information discussed during the call.
The exact format varies by company and brand. Depending on the approved communication plan, it may be a leaflet, card, small booklet, product-information piece or another permitted printed/reference format. The material and distribution process should follow the company’s current approval and compliance requirements.
LBL and visual aid are not the same thing
A pharma visual aid or detail aid is mainly used to support the live doctor discussion. LBL is mainly intended to remain as a reference after the discussion. Some content themes may overlap, but the communication job is different.
| Area | Visual Aid / Detail Aid | LBL |
|---|---|---|
| Main role | Guide the live product-detailing conversation | Support post-call reference or recall |
| Use | Handled by the MR during the call | May be left with the HCP where permitted |
| Format | Printed or digital | Often a leave-behind printed/reference piece |
| Content depth | Structured story with pages chosen for the discussion | Usually concise and designed for later reference |
Where LBL fits in a doctor call
- The MR prepares the objective and the current approved detailing material.
- The doctor discussion is led using the relevant visual/detail aid.
- The representative answers questions within approved information.
- At the close, permitted LBL may be provided as a concise reference when it is relevant and allowed by company process.
- Any follow-up is recorded in the normal field workflow.
LBL should not become a substitute for a clear conversation. A well-designed leave-behind is useful because it is easy to scan later, not because it repeats the entire detailing presentation.
What makes LBL useful?
- A clear headline and one primary communication objective.
- Readable product information rather than dense small text.
- Only current, approved claims and supporting information.
- Clear brand identity and useful reference structure.
- Version control so outdated material is not circulated.
- Contact or follow-up information only where appropriate and approved.
Because LBL stays behind after the MR leaves, its content should make sense without the representative standing beside it. That makes clarity, context and approval discipline particularly important.
LBL vs e-detailing
E-detailing is the digital workflow used to organize and present product content during the doctor interaction. LBL is the leave-behind/reference material. They can support the same brand communication plan, but they are not interchangeable.
Easy E-Detailing focuses on the digital presentation and field workflow: approved visual-aid content, doctor-wise detailing, projects, follow-ups and role-based Manager + MR field activity. It should not be described as automatically replacing a company’s approved LBL process. See how the Easy E-Detailing app handles the in-call presentation.
E-Detailing, Visual Aid and LBL in one view
| Term | What it is | Where it fits |
|---|---|---|
| E-Detailing | Electronic workflow for presenting and organizing approved product content | Primarily before/during the doctor call |
| Visual Aid / Detail Aid | The structured product story/material used to support the discussion | During the doctor call |
| LBL | Leave-Behind Literature/reference material | At or after the close of the interaction, where permitted |
Content governance still matters
Whether the material is a tablet visual aid or a physical LBL, pharma companies should use their current medical/legal approval process, version control and field training. Product claims and distribution practices may be subject to company policy and applicable requirements, so this page explains terminology rather than prescribing a universal promotional process.
For digital field execution, explore the Manager + MR features, our pharma detailing resource library.